317 related articles for article (PubMed ID: 35108421)
1. Disabled-2 overexpression mediates immune suppression in systemic lupus erythematosus by modulating Treg/Th17 cell differentiation.
Zhang J; Chang L; Sun Y; Qin M; Wang X; Guo Y
Clin Exp Pharmacol Physiol; 2022 May; 49(5):596-607. PubMed ID: 35108421
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
Front Immunol; 2021; 12():668760. PubMed ID: 34093566
[TBL] [Abstract][Full Text] [Related]
4. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
5. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
Chen M; Chen X; Wan Q
Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
8. Role of CD19
Zhu ZZ; Chen XH; Wei SR; Xu J; Wang YH; Wu WJ; Liu H; Mo HY
Int J Rheum Dis; 2023 Jun; 26(6):1048-1057. PubMed ID: 37012219
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.
Cai Z; Wong CK; Dong J; Jiao D; Chu M; Leung PC; Lau CBS; Lau CP; Tam LS; Lam CWK
Chin Med; 2016; 11():23. PubMed ID: 27134645
[TBL] [Abstract][Full Text] [Related]
10. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
12. SMURF1 inhibits the Th17 and Th17.1 polarization and improves the Treg/Th17 imbalance in systemic lupus erythematosus through the ubiquitination of RORγt.
Zhong W; Feng L; Tian W; Qu H; Xu H; Ning K; Liu L; Liu W; Gong X; Chen H
Mol Immunol; 2023 May; 157():186-194. PubMed ID: 37054520
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting
Ma S; Feng G; Li L; Li Z; Zhou X; Zhou Y; Zhang R
Lupus; 2023 Oct; 32(12):1430-1439. PubMed ID: 37852297
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
Fu D; Ma J; Gong Q; Senouthai S; Wang J; You Y; Pinhu L
Am J Transl Res; 2020; 12(10):6170-6186. PubMed ID: 33194022
[TBL] [Abstract][Full Text] [Related]
15. NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3.
Xie M; Wang J; Gong W; Xu H; Pan X; Chen Y; Ru S; Wang H; Chen X; Zhao Y; Li J; Yin Q; Xia S; Zhou X; Liu X; Shao Q
J Autoimmun; 2019 Aug; 102():96-113. PubMed ID: 31130368
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
17. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
Divekar AA; Dubey S; Gangalum PR; Singh RR
J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
19. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
20. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
